BioAmp Diagnostics
PrivateLast Round
Grant
Jan 15, 2023
Total Funding Raised
$1.58M
Company Overview
BioAmp Diagnostics is a biotechnology company that develops rapid, precision diagnostic tests designed to counteract antibiotic resistance by enabling medical providers to identify appropriate antibiotic treatments for bacterial infections.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BioAmp Diagnostics Comparables
Compare BioAmp Diagnostics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Astek Diagnostics | 85% | |
| FluoretiQ | 85% | |
| BacterioScan, Inc. | 82% |
BioAmp Diagnostics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jan 15, 2023 | ||||
| Accelerator | Oct 7, 2022 | ||||
| Grant | May 1, 2020 | ||||
| Grant | Feb 1, 2020 | ||||
| Accelerator | Apr 23, 2019 | ||||
Accelerator | Jun 14, 2017 |
BioAmp Diagnostics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Institute of Allergy and Infectious Diseases | Grant |
| Blue Bear Ventures | Accelerator |
| America's Seed Fund | Grant |
| CITRIS Foundry | Accelerator |
| Illumina Accelerator | Accelerator |
| National Science Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 15, 2023
$1M grant from the National Science Foundation.
- May 1, 2020
$225K grant from the National Science Foundation.
BioAmp Diagnostics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about BioAmp Diagnostics's valuation, stock price, and market status.
Is BioAmp Diagnostics a public or private company?
BioAmp Diagnostics is a private company.
What is the current stock price of BioAmp Diagnostics?
BioAmp Diagnostics is a private company with no public stock price. No recent secondary market data is available.
How much is BioAmp Diagnostics worth (valuation)?
Valuation information for BioAmp Diagnostics is not publicly available.
Can I buy BioAmp Diagnostics stock?
BioAmp Diagnostics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was BioAmp Diagnostics's last funding round?
BioAmp Diagnostics's most recent funding round was Grant on January 15, 2023.
Who are the main investors in BioAmp Diagnostics?
Key investors in BioAmp Diagnostics include CITRIS Foundry, National Science Foundation.
Will BioAmp Diagnostics IPO soon?
No public IPO plans have been announced for BioAmp Diagnostics.
How can I track BioAmp Diagnostics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor BioAmp Diagnostics's secondary market activity and sign up for updates.